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Abstract-To assess the (3-blocking potencies of three newly synthesized (3-blockers, i.e., S-596: dl-2 (3'-t-butylamino-2'-hydroxypropylthio)-4-(5'-carbamoyl-2' thienyl)-thiazole hydrochloride, K-351: 3,4-dihydro-8-(2-hydroxy-3-isopropyl aminopropoxy)-3-nitroxy-2H-1 -benzopyran, and N-696: 4,3-(tert-butylamino)-2 hydroxypropoxy) N-methylisocarbostyril hydrochloride, values of K; (inhibition constant) were obtained by the radioligand binding assay method using rat heart membrane treated with neuraminidase.
The pA2 values of these blockers as antagonists against the positive chronotropic and inotropic actions of isoproterenol were also determined by pharmacological methods using guinea pig atria. To assess the selectivity of these (3-blockers, pA2 values were also obtained in the isolated trachea using isoproterenol as an agonist. The order of potencies as assessed by K; and pA2 values were S-596>K-351 >N-696. When the K; values were plotted against the pA2 values together with the K, and pA2 values of our previous study (Horii et al., 1974; Nakazawa et al., 1978; Nakagawa et al., 1980; Nakagawa et al., 1983; , straight lines were obtained with r values of 0.93 (P<0.001) (positive chronotropic action) and 0.91 (P<0.001) (positive inotropic action), respectively.
Thus, the validity of using the 8-adre noceptor binding assay method developed in this laboratory using cardiac membrane treated with neuraminidase for assessment of the potencies of /9-adrenoceptor blockers in cardiac muscle was further substantiated.
Our previous report suggested that the / adrenoceptor binding assay method de veloped in our laboratory using cardiac membrane treated with neuraminidase could be used for assessment of newly synthesized l3-adrenergic antagonists because a sig nificant correlation (r=0.91) was observed between the potencies of (3-adrenoceptor antagonists as assessed by binding to the 8 adrenergic receptor (K;) and the potencies as assessed by pharmacological methods (pA2) by Nagatomo et al. (1, 2) . In the present study, the K1 values of three newly-syn thesized (3-blockers were determined using the binding assay method just mentioned and were plotted against the pA2 values obtained by a pharmacological method together with the K; and pA2 values of our previous reports (2) in order to further test the validity of using the method for assessment of (3 blocking potencies of the new compounds.
Materials and Methods
Binding assay: Preparations of the mem brane samples and 3H-dihydroalprenolol (3H DHA) (New England Nuclear, Co. Ltd: 90.0 Ci/mmole) binding assay were carried out with the method described previously (1, 2), using male Wistar rats weighing 200-300 g. After removal of the heart, ventricle muscles were minced with small scissors in 250 mM sucrose, 10 mM Tris-HCI, pH 7.4, and then homogenized twice using a Polytron homo genizer at setting 8 for 10 sec. The suspension was filtered through 4 layers of cheese-cloth. This suspension was treated with 0.3 M KCI and 25 mM sodium pyrophosphate and centrifuged at 177,000 g for 45 min. The pellets obtained were then treated with neuraminidase (6.2 unit/mg protein) (Sigma, Type V) in a medium containing 100 mM KCI, 10 MM MgCI2, 20 mM Tris-maleate, pH 7.4, at 25'C for 30 min. The suspension was again centrifuged at 177,000 g for 45 min, and the pellets were suspended in an incubation buffer (75 mM Tris-HCI, pH 7.4, 25 mM MgCI2).
In the binding assays, membrane sus pensions (0.4-0.6 mg protein) were incubated at 23°C with 3H-DHA (2.5 nM), and appropriate concentrations of the drugs in 60 mM Tris-HCI buffer, pH 8.0, 20 mM MgCI2 in a final volume of 1 ml. After 20 min, the incubation medium was filtered under reduced pressure through Whatman glass fiber filters (GF/C), and the filters were washed with 3x5 ml of cold buffer. The radioactivity of 3H-DHA bound to the membrane remaining in the filters in the absence (total) and the presence (non specific) of drugs was determined by liquid scintillation counting, and the specific binding was defined as the difference between the total and the non-specific binding. As described previously (1, 2), the specific binding of 2.5 nM 3H-DHA reached equilli brium after 15 min at 23°C and constituted 40-60% of the total binding. Values of K; (inhibition constant) of each (3-blocker were calculated according to the equation described in the previous paper (2) . Protein concentration was determined using the method of Lowry et al. (3) .
Pharmacological observations: Beta blocking actions were studied using the method described previously (4) . The right and left atria of guinea-pig were used for the assessment of the antagonistic potencies against the positive chronotropic and iso tropic actions of isoproterenol (' -effect).
The rate of the spontaneous contraction of the right atria was recorded on an ink-writing oscillograph to test the positive chronotropic actions. The left atria stimulated electrically by a square-wave stimulator (Nihon Kohden MSE-40)
at the frequency of 1 Hz with voltages 30% above the threshold were used to evaluate the inotropic effects. Their contractile tension was recorded on an ink writing oscillograph with a strain-gauge transducer and a carrier amplifier. Isolated tracheal smooth muscle preparations of the guinea pig were used to assess the antago nistic effects towards the Q2-receptor. Seven tracheal rings removed from guinea pigs were sutured together and mounted vertically in a 5 ml organ bath. The contractile tension of the preparation was recorded on a poten tiometric recorder (Hitachi QPD-74). Relax ation of the preparation was induced by isoproterenol.
Drugs were administered in a cummulative fashion, and pA2 values were caluculated using the equation:
where A is a dose of drug at which the con traction was 50% of the maximum obtainable without the same compound, B is a dose contrition of drug at which was 50% of the maximum in the presence of the same compound and C is a dose of the drug.
The bathing solution used contained in mM: NaCI, 118; CaCl2, 2.5; NaHC03 24.9; MgSO4 1.2; KH2PO4 1.2, glucose 12. The temperature of the solution was maintained at 32±0.30°C. The solution was equilibrated with a mixture of 95% 02 and 5% C02. After dissection, all preparations were allowed to equilibrate for one hour prior to addition of any drugs.
The r3-blockers used were S-596: dl-2 (3'-t-butylamino-2'-hydroxypropylthio) -4 (5'-carbamoyl-2'-thienyl) -thiazole hydro chloride (5), K-351 : 3,4-dihydro-8-(2 hydroxy-3-isopropylami nopropoxy) -3 nitroxy-2H-1 -benzopyran (6) and N-696: 4,3 (tert-butylamino) -2-hydroxypropoxy) N-methyl-isocarbostyril hydrochloride (7). These chemicals were kindly donated by Sumitomo Chemical Co., Ltd (S-596), Kowa Table 1 , the values of the K1 for S-596, K-351 and N-696 were 1.52±0.88, 19.85±6.00 and 159.87+41.80 nM, respec tively. The Ki value of S-596 (1.52 nM), the lowest among the three, was lower than those of pindolol (9.83 nM) and propranolol (5.18 nM), while the Ki value of K-351 (19.85 nM) was higher than those of pindolol and propranolol.
Results

As shown in
The K; value of N-696 (159.87 nM) was almost the same as that of labetalol (127.08 nM).
The pA2 values of S-596, K-351 and N-696 as antagonists against the positive inotropic and chronotropic effects in the heart and the relaxant effects in the trachea of isoproterenol are alsc listed in Table 1 . The order of the (3-blocking potency in the heart was S-596> K-351 >N-696, while the potencies of K-351 and N-696 in the trachea were almost the same. Thus, as regards to the 13-blocking activity of N-696, there existed a certain degree of selectivity towards the 132-receptor. and pA2 values using cardiac membrane preparations without enzyme treat ment in the guinea-pig atria. However, as shown in our previous paper (2) , neura minidase treatment is needed for obtaining reproducible data and higher yields of 13 adienoceptor binding sites. With i3,-selective ,3-blockers, especially with practolol and atenolol, there was a tendency for pA2 obtained by the biological assay method to be greater than K; obtained with the radioligand binding assay method. This may probably be due to the use of 3H DHA as a radioligand. As is well known, 3H DHA can bind to both (3-1 and 3-2 adre noceptors;
and as Minneman et al. (11) already reported, rat cardiac muscle contains both i3-1 and ,3-2 adrenoceptor sites. None of the three new (3-blockers used in the present study were selective ;3-blockers, and as expected, no gross dissociation between pA2 and K; was observed with these three compounds.
As the basic structure, (3-blockers possess either an arylethanolamine or an aryloxy propanolamine moiety and have substituents at the para or ortho position of aryloxypro panolamine (12). It is known that the chemicals (propranolol, pindolol, oxprenolol or alprenolol) with substituents at the crtho position show higher affinity to (3-adrenergic receptor binding sites and lower selectivity than the compounds with substituents at the para position (atenolol, practolol, acebutolol, metoprolol or sotalol). In this respect, S-596 and N-696 are unique in that the aryl nucleus was replaced by the heterocyclic nucleus. It was found that the potency of N-696 was intermediate, equal to that of acebutolol, while S-596 with a hetero cyclic nucleus and a N-substituted thiopropanolamine moiety attached to a hetero cyclic nucleus (13) had the lowest values of Ki or highest values of pA2. K-351 with a pyran nucleus at the para position of aryloxypropanolamine showed potencies slightly higher than those of non selective (3- 
